COMMON IMATINIB: A AFFORDABLE OPTION?

The arrival of common imatinib represents a significant chance for patients battling a certain type of cancer and other illnesses. Original brand-name imatinib, branded as Gleevec, carries a high price tag, frequently presenting a challenge for accessibility for some individuals. Common versions,